We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $138M
1-Year Est. Return 7.66%
This Fund
S&P 500
This Quarter Est. Return
+1.88%
1 Year Est. Return
+7.66%
3 Year Est. Return
+26.37%
5 Year Est. Return
+15.44%
10 Year Est. Return
+55.31%
AUM
$741M
AUM Growth
+$6.19M
Cap. Flow
-$3.65M
Cap. Flow %
-0.49%
Top 10 Hldgs %
17.38%
Holding
383
New
100
Increased
54
Reduced
135
Closed
78

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$21.2M
2
TJX icon
TJX Companies
TJX
+$19.9M
3
VFC icon
VF Corp
VFC
+$8.2M
4
NWL icon
Newell Brands
NWL
+$6.68M
5
MDT icon
Medtronic
MDT
+$6.38M

Sector Composition

Rank Sector Weight
1 Financials 17.29%
2 Technology 13.99%
3 Healthcare 13.29%
4 Industrials 10.17%
5 Consumer Discretionary 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$26.3M 3.55%
733,440
-62,556
-8% -$2.06M
TFCF
2
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$15.1M 2.03%
+474,007
New +$14.2M
TGT icon
3
Target
TGT
$65.6B
$14.7M 1.98%
266,388
+177,247
+199% +$11M
WFC icon
4
Wells Fargo
WFC
$261B
$12.7M 1.72%
228,975
-3,137
-1% -$178K
BAC icon
5
Bank of America
BAC
$435B
$11.6M 1.56%
490,694
-20,169
-4% -$479K
C icon
6
Citigroup
C
$222B
$9.98M 1.35%
166,864
-6,332
-4% -$375K
VIAB
7
DELISTED
Viacom Inc. Class B
VIAB
$9.9M 1.34%
212,391
-4,955
-2% -$209K
EXC icon
8
Exelon
EXC
$47.2B
$9.77M 1.32%
380,751
-9,057
-2% -$231K
MSFT icon
9
Microsoft
MSFT
$3.45T
$9.64M 1.3%
146,393
-20,265
-12% -$1.3M
BIIB icon
10
Biogen
BIIB
$30B
$9.13M 1.23%
33,376
+16,910
+103% +$4.78M
CVS icon
11
CVS Health
CVS
$133B
$9.12M 1.23%
116,223
-37,855
-25% -$3.02M
YUM icon
12
Yum! Brands
YUM
$41.8B
$8.82M 1.19%
+138,000
New +$8.99M
VTRS icon
13
Viatris
VTRS
$20.4B
$8.16M 1.1%
209,301
-141,272
-40% -$5.69M
JPM icon
14
JPMorgan Chase
JPM
$935B
$7.95M 1.07%
90,495
+3,156
+4% +$278K
GE icon
15
GE Aerospace
GE
$374B
$7.87M 1.06%
55,095
-61
-0.1% -$8.83K
EW icon
16
Edwards Lifesciences
EW
$49.6B
$7.79M 1.05%
+248,391
New +$7.78M
KEY icon
17
KeyCorp
KEY
$24.2B
$7.78M 1.05%
437,297
-16,160
-4% -$296K
ALLY icon
18
Ally Financial
ALLY
$13.2B
$7.75M 1.05%
381,212
-25,448
-6% -$540K
ZTS icon
19
Zoetis
ZTS
$32.4B
$7.37M 0.99%
+138,155
New +$7.47M
QCOM icon
20
Qualcomm
QCOM
$155B
$7.2M 0.97%
125,502
+81,094
+183% +$4.71M
JNJ icon
21
Johnson & Johnson
JNJ
$618B
$7.2M 0.97%
57,770
+9,160
+19% +$1.09M
META icon
22
Meta Platforms (Facebook)
META
$1.42T
$7.06M 0.95%
49,712
-2,492
-5% -$333K
HIG icon
23
Hartford Financial Services
HIG
$38.9B
$6.67M 0.9%
138,795
-3,555
-2% -$172K
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.36T
$6.51M 0.88%
153,660
-4,160
-3% -$175K
GOOG icon
25
Alphabet (Google) Class C
GOOG
$4.36T
$6.44M 0.87%
155,300
-2,680
-2% -$110K

Similar funds

Stoneridge Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Stoneridge Investment Partners held 383 positions worth $741M, up 0.84% from $735M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stoneridge Investment Partners's Q1 2017 filing shows 100 new, 54 increased, 135 reduced and 78 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class B: 474,007 shares worth $15.1M. The largest sale was Abbott, an estimated $21.2M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Stoneridge Investment Partners's largest Q1 2017 buy was Twenty-First Century Fox, Inc. Class B: 474,007 shares worth $15.1M.
  • Stoneridge Investment Partners added most to Target in Q1 2017, an estimated $11M increase.
  • Stoneridge Investment Partners's biggest Q1 2017 reduction was Viatris, cutting an estimated $5.69M.
  • Stoneridge Investment Partners fully exited Abbott in Q1 2017, selling an estimated $21.2M.
  • Stoneridge Investment Partners's ten largest holdings make up 17% of its $741M portfolio in Q1 2017.
  • Stoneridge Investment Partners opened 100 new positions and closed 78 in Q1 2017.
  • Stoneridge Investment Partners's portfolio value rose 0.84% quarter-over-quarter to $741M.

Based on Stoneridge Investment Partners's 13F filing for Q1 2017, filed 1 May 2017.